Comparing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS-HIPEC) Using Mitomycin-C Versus Melphalan for Colorectal Peritoneal Carcinomatosis

NCT03073694 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Cancer, Appendiceal
ColoRectal Cancer

Interventions

DRUG: Mitomycin c
DRUG: Melphalan

Sponsor

University of Kansas Medical Center